Plain-English translation of NCT06463236 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new management process designed to help doctors treat anemia — a condition where you don't have enough healthy red blood cells — more effectively in patients who receive regular hemodialysis. Some patients will receive care following a standardized, evidence-based treatment approach, while others will receive the usual care their doctors typically provide. The study wants to see if the standardized approach leads to better control of anemia and helps patients maintain healthier blood counts.
Anemia is very common in dialysis patients and can make you feel tired and weak. Right now, doctors across different clinics manage anemia in different ways, and not all patients reach healthy blood count levels. This trial exists to see if using clear, standardized guidelines helps doctors manage this condition better and more consistently.
If you join this study, you'll continue your regular dialysis appointments as usual. Depending on which group you're assigned to, your doctors will either follow a new standardized anemia treatment protocol or continue with their usual approach. Throughout the study, your blood counts and anemia management will be monitored to see how well the treatment is working. The study will last at least 6 months while you remain on dialysis.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China